Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study

Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study

© 2017 The Authors. Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. Objectives: The purpose of this study was to assess the safety and performance of Stellarex Drug-coated balloon (DCB). Background: DCB coatings differ in excipients, paclitaxel dose, and coating...

Full description

Bibliographic Details
Main Authors: Schroë, H., Holden, A., Goueffic, Y., Jansen, Shirley, Peeters, P., Keirse, K., Ito, W., Vermassen, F., Micari, A., Blessing, E., Jaff, M., Zeller, T.
Format: Journal Article
Published: 2018
Online Access:http://hdl.handle.net/20.500.11937/73398

Internet

http://hdl.handle.net/20.500.11937/73398

Similar Items